rs3750996

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001382567.1(STIM1):​c.*172A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0152 in 898,664 control chromosomes in the GnomAD database, including 1,021 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 125 hom., cov: 32)
Exomes 𝑓: 0.016 ( 896 hom. )

Consequence

STIM1
NM_001382567.1 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.63

Publications

19 publications found
Variant links:
Genes affected
STIM1 (HGNC:11386): (stromal interaction molecule 1) This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3' end of this gene situated 1.6 kb from the 5' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
STIM1 Gene-Disease associations (from GenCC):
  • myopathy, tubular aggregate, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
  • Stormorken syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, PanelApp Australia
  • tubular aggregate myopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • combined immunodeficiency due to STIM1 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 11-4091970-A-G is Benign according to our data. Variant chr11-4091970-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 1219172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.2 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001382567.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STIM1
NM_001382567.1
MANE Select
c.*172A>G
3_prime_UTR
Exon 13 of 13NP_001369496.1H0YDB2
STIM1
NM_001277961.3
c.*172A>G
3_prime_UTR
Exon 12 of 12NP_001264890.1G0XQ39
STIM1
NM_001382566.1
c.*172A>G
3_prime_UTR
Exon 12 of 12NP_001369495.1A0A8V8TNW0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STIM1
ENST00000526596.2
TSL:5 MANE Select
c.*172A>G
3_prime_UTR
Exon 13 of 13ENSP00000433266.2H0YDB2
STIM1
ENST00000616714.4
TSL:1
c.*172A>G
3_prime_UTR
Exon 12 of 12ENSP00000478059.1G0XQ39
STIM1
ENST00000300737.8
TSL:1
c.*172A>G
3_prime_UTR
Exon 12 of 12ENSP00000300737.4Q13586-1

Frequencies

GnomAD3 genomes
AF:
0.0107
AC:
1632
AN:
151900
Hom.:
126
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00131
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00511
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.210
Gnomad SAS
AF:
0.0740
Gnomad FIN
AF:
0.000473
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000427
Gnomad OTH
AF:
0.0115
GnomAD4 exome
AF:
0.0161
AC:
12014
AN:
746646
Hom.:
896
Cov.:
10
AF XY:
0.0183
AC XY:
7022
AN XY:
384526
show subpopulations
African (AFR)
AF:
0.000694
AC:
13
AN:
18724
American (AMR)
AF:
0.0100
AC:
293
AN:
29204
Ashkenazi Jewish (ASJ)
AF:
0.000274
AC:
5
AN:
18222
East Asian (EAS)
AF:
0.202
AC:
6585
AN:
32522
South Asian (SAS)
AF:
0.0713
AC:
4197
AN:
58856
European-Finnish (FIN)
AF:
0.000476
AC:
15
AN:
31540
Middle Eastern (MID)
AF:
0.00295
AC:
8
AN:
2712
European-Non Finnish (NFE)
AF:
0.000455
AC:
236
AN:
518580
Other (OTH)
AF:
0.0182
AC:
662
AN:
36286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
581
1163
1744
2326
2907
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0107
AC:
1627
AN:
152018
Hom.:
125
Cov.:
32
AF XY:
0.0127
AC XY:
944
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41474
American (AMR)
AF:
0.00510
AC:
78
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.210
AC:
1081
AN:
5146
South Asian (SAS)
AF:
0.0737
AC:
354
AN:
4806
European-Finnish (FIN)
AF:
0.000473
AC:
5
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000427
AC:
29
AN:
67966
Other (OTH)
AF:
0.0119
AC:
25
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
72
144
217
289
361
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00235
Hom.:
11
Bravo
AF:
0.0106
Asia WGS
AF:
0.106
AC:
368
AN:
3478

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
17
DANN
Benign
0.90
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3750996; hg19: chr11-4113200; COSMIC: COSV56157285; COSMIC: COSV56157285; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.